A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions:

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 5, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

April 1, 2026

Conditions

Healthy Adult Male and Female Volunteers

Interventions

DRUG

Torasemide tablet 10 mg

Tablets by Berlin-Chemie AG (Germany)

DRUG

Unat® 10 tablets (Torasemide 10 mg)

Tablets by Viatris Healthcare GmbH (Germany)

Trial Locations (1)

RECRUITING

LLP MedStartUp, Almaty

All Listed Sponsors

lead

Berlin-Chemie AG Menarini Group

INDUSTRY